4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-020106
CHIEF FINANCIAL OFFICER sold 24,248 shares at $24.79 ($601,108)
- CHIEF FINANCIAL OFFICER acquired 24,248 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-07-23 | Option exercise 10b5-1 | +24,248 | $11.10 | $269,153 | 43,501 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-07-23 | Sale 10b5-1 | −24,248 | $24.79 | $601,108 | 19,253 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-07-23 | Option exercise · Share Option 10b5-1 | −24,248 | 40,412 | D | ||
| Open-market sales · 24,248 sh · avg $24.79 · $601,108 | |||||||
Loading xslF345X05/form4-07252024_080736.xml…